Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.

British journal of haematology - 1 Oct 2020

Khialani Deeksha, le Cessie Saskia, Lijfering Willem M, Cannegieter Suzanne C, Rosendaal Frits R, van Hylckama Vlieg Astrid

Abstract excerpt

It is not known whether the synergistic effect of genetic markers, increasing the risk of venous thrombosis (VT), and combined oral contraceptives (COC) use varies between different types of progestogens in these preparations. We investigated the joint effect of genetic risk factor, that is, F5 rs6025, F2 rs1799963, and FGG rs2066865 mutations, and different progestogens on the risk of VT. The constrained maximum...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Blood Coagulation Factors
Share to Genetic Variation
Share to Risk Factors
Share to Venous Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 32342502
DOI: 10.1111/bjh.16666
PMCID: PMC7586802

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk.PMID 32342502Read ↗

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study.Semantic proximity Read ↗

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk.Semantic proximity Read ↗

Hormonal contraception, thrombosis and age.Semantic proximity Read ↗

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.Semantic proximity Read ↗

Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Semantic proximity Read ↗

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review.Semantic proximity Read ↗

Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.Semantic proximity Read ↗

A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis.Semantic proximity Read ↗

Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Genetic variation in the first-pass metabolism of ethinylestradiol, sex hormone binding globulin levels and venous thrombosis risk.Semantic proximity Read ↗

Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.